Gemini Therapeutics Shares Rise After Disc Medicine Gets FDA Designation - MarketWatch

Retrieved on: 2022-12-27 13:28:10

Tags for this article:

Click the tags to see associated articles and topics

Gemini Therapeutics Shares Rise After Disc Medicine Gets FDA Designation - MarketWatch. View article details on hiswai:

Excerpt

All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data ...

Article found on: www.marketwatch.com